SCHEMBL7726393

SCHEMBL7726393

COC(=O)[C@@H]1C[C@@H](N(C(=O)CN)C(=O)OC(C)(C)C)CN1C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.39
MMP2 P08253 2/20 0.37
ANPEP P15144 2/20 0.37
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 1/20 0.35
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
CETP P11597 1/20 0.33
P2RX3 P56373 1/20 0.33
HTRA1 Q92743 1/20 0.32
PEPD P12955 2/20 0.32
XPNPEP1 Q9NQW7 1/20 0.32
CCR2 P41597 1/20 0.31
HSD11B1 P28845 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7733526 1.00 PTPN1 (0.39) PTPN1MMP2ANPEPNR1H2NR1H3
SCHEMBL7733813 1.00 PTPN1 (0.39) PTPN1MMP2ANPEPNR1H2NR1H3
SCHEMBL7728185 0.89 HSD17B10 (0.34) PTPN1NR1H2NFKB1NFKB2RELA
SCHEMBL7727961 0.89 HSD17B10 (0.34) PTPN1NR1H2NFKB1NFKB2RELA
SCHEMBL7726101 0.89 HSD17B10 (0.34) PTPN1NR1H2NFKB1NFKB2RELA
SCHEMBL7729049 0.88 PTPN1 (0.38) PTPN1MMP2ANPEPNR1H2NR1H3
SCHEMBL7729134 0.88 PTPN1 (0.38) PTPN1MMP2ANPEPNR1H2NR1H3
SCHEMBL7729324 0.85 PTPN1 (0.34) PTPN1MMP2ANPEPNR1H2NR1H3
SCHEMBL21285787 0.83 HSD11B1 (0.42) PTPN1MMP2ANPEPNR1H2NR1H3
SCHEMBL8149676 0.82 NFKB1 (0.34) NR1H2NFKB1NFKB2RELACETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed